Gene: ARHGAP18
Official Full Name: Rho GTPase activating protein 18provided by HGNC
Gene Summary: Enables GTPase activator activity. Involved in several processes, including regulation of actin filament polymerization; regulation of small GTPase mediated signal transduction; and small GTPase-mediated signal transduction. Located in cytosol; nuclear speck; and plasma membrane. Part of cytoplasmic microtubule and ruffle. Implicated in schizophrenia. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22134 | ARHGAP18 Knockout cell line (HeLa) | Human | ARHGAP18 | 1:3~1:6 | Negative | Online Inquiry |
KO22135 | ARHGAP18 Knockout cell line (HCT 116) | Human | ARHGAP18 | 1:2~1:4 | Negative | Online Inquiry |
KO22136 | ARHGAP18 Knockout cell line (HEK293) | Human | ARHGAP18 | 1:3~1:6 | Negative | Online Inquiry |
KO22137 | ARHGAP18 Knockout cell line (A549) | Human | ARHGAP18 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP18 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the ARHGAP18 gene, which encodes the Rho GTPase-activating protein 18. This gene plays a critical role in regulating the Rho family of GTPases, important signaling molecules involved in various cellular processes, including cytoskeletal dynamics, cell migration, and proliferation. By creating knockout models that lack functional ARHGAP18 protein, researchers can investigate the downstream effects of its absence on cellular behavior, providing insights into its biological significance.
These cell lines operate through a simple yet effective mechanism wherein the ARHGAP18 gene has been selectively ablated, leading to the loss of its encoded protein. This approach allows for detailed analysis of the gene's contribution to key pathways, enabling researchers to discern its role in physiological and pathological contexts. The knockout model is particularly valuable in studying cancer biology, developmental processes, and various disorders linked to dysregulated Rho GTPase activity.
The scientific importance of ARHGAP18 Gene Knockout Cell Lines extends to both research and clinical settings. In research, these models serve as essential tools for identifying potential therapeutic targets, unraveling mechanisms underlying disease states, and validating drug candidates. Clinically, understanding ARHGAP18 can lead to advancements in targeted therapies that enhance treatment strategies for conditions associated with dysregulated Rho signaling.
When compared to alternative models, the ARHGAP18 Gene Knockout Cell Lines offer unique advantages, such as greater specificity in gene manipulation and the absence of off-target effects commonly encountered with conventional knockdown approaches. This specificity promotes more reliable data and reproducible results, essential factors for rigorous scientific investigation.
For researchers, clinicians, and pharmaceutical companies, the value of ARHGAP18 Gene Knockout Cell Lines is paramount. They provide clarity in experimental outcomes, drive innovations in therapeutic development, and enhance our understanding of complex biological systems. With expertise in biotechnology and a commitment to quality, our company is dedicated to delivering high-caliber research tools that empower the scientific community to make significant advancements in gene function studies and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.